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SUMMARY
Undifferentiated cell Transcription Factor 1 (UTF1) is a chromatin-bound protein
involved in stem cell differentiation. It was initially reported to be restricted to stem
cells or germinal tissues. However, recent work suggests that UTF1 is also expressed
in somatic cells and that its expression may increase during carcinogenesis. To fur-
ther clarify the expression profile of UTF1, we evaluated UTF1 expression levels
immunohistochemically in eight normal human epithelia (from breast, prostate,
endometrium, bladder, colon, oesophagus, lung and kidney) and their corresponding
tumours as well as in several epithelial cell lines. We showed UTF1 staining in nor-
mal and tumour epithelial tissues, but with varying intensities according to the tissue
location. In vitro analyses also revealed that UTF1 is expressed in somatic epithelial
cell lines even in the absence of Oct4A and Sox2, its two main known regulators.
The comparison of UTF1 levels in normal and tumoral tissues revealed significant
overexpression in endometrial and prostatic adenocarcinomas, whereas lower inten-
sity of the staining was observed in renal and colic tumours, suggesting a potential
tissue-specific function of UTF1. Altogether, these results highlight a potential dual
role for UTF1, acting either as an oncogene or as a tumour suppressor depending on
the tissue. These findings also question its role as a specific marker for stem cells.
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Undifferentiated cell Transcription Factor 1 (UTF1) has been
described as a transcriptional co-activator which was first
identified in mouse embryonic stem cells (ESC) (Okuda
et al. 1998). Several studies on ESC have described UTF1 as
a transcriptional repressor, and it has been proposed as an
important sensitive pluripotency marker (Fukushima et al.
1999; van den Boom et al. 2007; Tan et al. 2007). Available
data indicate that UTF1 expression is regulated by a dimer
composed of Oct4A and Sox2 proteins acting on a specific
fixation sequence located in the 3’ flanking region (Nishim-
oto et al. 1999). To date, one isoform of this protein and
no pseudogenes have been identified in humans. Investiga-
tions on human embryonic carcinoma and ESC demon-
strated that UTF1 is a nuclear protein that is excluded from
the nucleoli and strongly associated with chromatin during
all phases of cell division (Kooistra et al. 2009). In addition,
UTF1 was proposed to be expressed in the early phases of
embryonic development and to be quickly downregulated
during this process (Okuda et al. 1998).
In adults, UTF1 expression was reported to be restricted
to germinal tissues (van Bragt et al. 2008; Kristensen et al.
2008). The expression pattern of UTF1 in somatic tissues
has not been widely studied. Nevertheless, recent investiga-
tions revealed its presence in normal epithelium from pros-
tate, uterine cervix and skin (Kristensen et al. 2010;
Reinisch et al. 2011; Guenin et al. 2012).
Like many SC and pluripotency markers, such as Oct4
and Sox2, UTF1 has been assessed for its potential implica-
tion in tumorigenesis, and it was shown to be strongly
expressed in germ cell tumours (Kristensen et al. 2008;
© 2014 The Authors.
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Wang et al. 2010). However, few data are available about
its expression in the somatic tumour context. In brain
tumours, UTF1 mRNA levels could help to discriminate
between grade I–III and grade IV neuroblastoma tumours,
whereas it was shown to be expressed at the same level in
healthy epidermis and in skin squamous cell carcinoma
(SCC) (Melone et al. 2009; Reinisch et al. 2011). In addi-
tion, we have previously shown that UTF1 overexpression
was associated with cervical carcinogenesis (Guenin et al.
2012). Nevertheless, no further data are available about its
expression profile in other human normal epithelia and their
corresponding tumours.
Here, using immunohistochemistry, we screened the
expression pattern of UTF1 in a panel of normal and can-
cerous epithelial tissues including breast, prostate, endome-
trium, bladder, colon, oesophagus, lung and kidney. We
found that UTF1 was widely expressed in all epithelia or
cell lines, although differentially, and was mainly localized
in the nucleus. Also, by Western blotting, we showed UTF1
expression in several epithelial cell lines, even in the absence
of its well-described regulators Oct4A and Sox2. Interest-
ingly, the comparison of UTF1 expression levels in normal
and cancer tissues revealed significant overexpression in
endometrial and prostatic adenocarcinomas and sharp
downregulation in colon and kidney carcinomas, suggesting
a potential tissue-specific role of this protein.
Material and methods
Tissue samples
Normal and cancer formalin-fixed paraffin-embedded epithe-
lial sections were obtained from the Tissue Bank of the Uni-
versity Hospital of Liege. Normal human epithelia included
94 cases distributed as follows: 20 specimens from endome-
trium, 13 from prostate, 14 from breast, 11 from colon, 10
from bladder and lung, 9 from oesophagus and 7 from kid-
ney. We also evaluated 104 cases of corresponding tumours
from endometrium (n = 29), colon and bladder (n = 12),
oesophagus (n = 14), kidney and prostate (n = 10), breast
(n = 9) and lung (n = 8). The study was approved by
the ethics committee of the University Hospital of Liege
(reference: B707201111603).
Tumour cell lines and cell culture
The teratocarcinoma cell line NCCIT (kind gift from Prof.
Luc Grobet, Laboratory of Animal Histology and Embryol-
ogy, University of Liege, Belgium) was cultivated in RPMI-
1640 (Gibco, Carlsbad, CA, USA). DU146 cells (prostate)
(kind gift from Dr Akeila Bellahcene, Laboratory of
Research on Metastasis, University of Liege, Belgium) were
cultivated in DMEM (Gibco). Ishikawa cells (endometrium)
were purchased from Sigma-Aldrich (Sigma, St Louis, MO,
USA) and cultivated in EMEM (Gibco). EO33 cell lines
(oesophagus) were purchased from the European Collection
of Cell Cultures and were cultivated in RPMI-1640.
HCT116 (colon) and Detroit 562 (pharynx) cell lines were
purchased from the American Type Culture Collections and
were cultivated in McCoy’s (Gibco) and MEM respectively.
All cell culture media were supplemented with 10% foetal
bovine serum (Gibco), 2 mM L-glutamine (Gibco), 1%
sodium pyruvate (Gibco), 1% non-essential amino acids
(Gibco), 100 U/ml penicillin G and 100 mg/ml streptomycin
(Gibco). NCCIT treated or not with retinoic acid (all-trans
retinoic acid, 10 mM, 11 days, Sigma) were used as negative
and positive controls of UTF1 expression respectively.
Immunohistochemistry (IHC)
Tissue sections were deparaffinized in xylene and rehydrat-
ed through graded ethanol baths. For UTF1 expression,
heat-induced antigen retrieval was performed in 10 mM cit-
rate buffer (pH 6.0) using a microwave oven (5 min at
750 W followed by 15 min at 350 W). After treatment
with endogenous peroxidase inhibitor (Dako, Glostrup,
Danemark) for 5 min and blocking of endogenous biotin
activity using Avidin (Vector, Burlingam, CA, USA) for
30 min, non-specific binding sites were blocked for 10 min
in protein block serum-free solution (Dako). Sections were
then incubated overnight at 4 °C with a mouse monoclonal
anti-human UTF1 antibody (1:500, clone 5G10.2,
MAB4337, Millipore, Darmstadt, Germany). The immuno-
gen used to produce this antibody was a recombinant GST
Fusion protein (human UTF1). We previously assessed the
specificity of this antibody by Western blot using cells over-
expressing the human protein (Guenin et al. 2012). This
specificity was also validated by the fact that, up to now,
no related protein or isoform was reported in human tissue,
contrary to murine UTF1 which has two isoforms (Okuda
et al. 1998). Negative controls included replacement of the
primary antibody with either PBS or normal mouse IgG1.
A secondary staining system (LSAB2, Dako) was used
according to the manufacturer’s instructions. The reaction
was then visualized using diaminobenzidine (DAB,
Dako), and sections were counterstained with Mayer
haematoxylin.
Scoring of immunohistochemical
To assess IHC results, UTF1 staining was scored based on
the intensity and percentage (or extent) of cells that stained
positively according to an arbitrary scale. For staining inten-
sity, 0 represented samples in which the immunoreactivity
was undetectable, whereas 1, 2 and 3 denoted samples with
low, moderate and strong staining respectively. For staining
extent, 0, 1, 2 and 3 represented samples in which the
immunoreactivity was, respectively, detectable in <6%, in
6% to 25%, in 26% to 75% and in more than 75% of the
tumour cells. To provide a global score for each case, the
results obtained using the two scales were multiplied, yield-
ing a single scale of 0, +1, +2, +3, +4, +6 and +9 (Guenin
et al. 2012). For scoring only the nuclear staining was taken
into consideration.
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Protein isolation and Western blotting
Cultured cells were harvested at 60–80% confluence and
lysed in RIPA buffer (Pierce, Rockford, IL, USA) supple-
mented with 1 mM phenylmethyl sulphonyl fluoride (Sigma)
and protease inhibitors (Roche, Vilvoorde, Belgium).
Extracted proteins were quantified using BCA protein assay
(Pierce) and separated by electrophoresis through 4–12% Nu-
PAGE polyacrylamide gel (Invitrogen, Carlsbad, CA, USA)
and transferred onto a PVDF membrane. The membrane was
then blocked for 25 min in blocking buffer (5% skimmed
milk in TBS-Tween-20, 0.1%) and incubated overnight at
4 °C with anti-human UTF1 (1:500, mouse monoclonal clone
5G10.2, Millipore), anti-Oct4A (1:500, mouse monoclonal
sc-5279, Santa Cruz Biotechnology) or anti-Sox2 (1:1000
rabbit monoclonal clone D6D9, Cell Signaling) or for 2 h at
room temperature with anti-Actin (1:2000, Sigma) antibod-
ies. The membrane was then incubated with the appropriate
secondary antibodies (Amersham Biosciences, Piscataway,
NJ, USA). After washing, proteins were detected using an
enhanced chemiluminescence system ECL Plus (Pierce).
Data analysis
All results are given as mean values  SE. Statistical analy-
ses were conducted and graphs drawn using GRAPHPAD PRISM
5 software (San Diego, CA, USA). The statistical tests used
are indicated in the figure legends. All results were consid-
ered significant at the 5% level (P < 0.05).
Results
Expression and distribution of UTF1 protein in normal
human epithelia
In this study, we characterized UTF1 expression in normal
human tissues using a previously described monoclonal anti-
human UTF1 (Kristensen et al. 2008; Wang et al. 2010;
Reinisch et al. 2011; Guenin et al. 2012). Figure 1 shows
representative images of UTF1 staining in each tissue type,
with their corresponding negative controls (capital and
lower case letters respectively). These results showed that
UTF1 is expressed in all tested tissues and that staining is
almost exclusively located in the epithelial components.
UTF1 was rarely observed in cells within the stroma or in
infiltrating lymphocytes, and staining was almost always
confined to the nuclei.
Semi-quantitative analysis of the staining showed that
UTF1 is differentially expressed according to tissue type. In
endometrial epithelium (Figure 1A), UTF1 staining was
remarkably low and stromal cell staining was seen in some
cases (3/14). In breast epithelium (Figure 1B), UTF1 showed
a similar pattern of expression in both ducts and lobules.
Nevertheless, it should be noted that staining was mainly
detected in luminal epithelial cells, whereas weak or no stain-
ing was detected in the basal myoepithelial layer. In the blad-
der (Figure 1C), the transitional epithelium showed low to
moderate UTF1 staining in almost all epithelial cells. How-
ever, in many section areas, luminal epithelial cells were
stained more intensely than underlying cells. Within the pros-
tate (Figure 1D), epithelial cells were positively stained for
UTF1. Importantly, as in breast and bladder epithelium,
prostatic basal cells exhibited absent or weak UTF1 expres-
sion in comparison with luminal epithelial cells (Supplemen-
tal Figure 1). In colon epithelium (Figure 1E), UTF1 was
mostly detected in all cells within crypts. In the oesophagus
(Figure 1F), both squamous and glandular epithelial cells
were positively stained. In the lungs (Figure 1G), staining
was detected in all epithelial cells within the bronchioles and
alveoli. In the kidneys (Figure 1H), epithelial cells showed
strong nuclear UTF1 staining in both the distal and proximal
tubules. Testicular tissue was used as a positive control as
previously described (Kristensen et al. 2008) (Figure 1I).
To assess the UTF1 expression level within the epithelia,
staining was evaluated using a semi-quantitative method.
The results are shown in Figure 2 and Table 1. On the basis
of the mean IHC score, these tissues could be classified into
three categories (Figure 2): (a) tissues with weak UTF1
expression (score <3): breast prostate and endometrium; (b)
tissues with weak to moderate UTF1 expression: bladder,
colon, oesophagus and lung epithelium (score >3 and <6);
and (c) tissues with strong UTF1 expression (score >6): kid-
ney. Table 1 presents the statistical analysis of the staining
intensity.
Expression of UTF1 with Sox2 and Oct4A in somatic
epithelial cell lines
We investigated UTF1 expression in somatic epithelial can-
cer cell lines originating from various tissues. Positive and
negative controls were, respectively, undifferentiated and
differentiated (using all-trans-retinoic acid) human teratocar-
cinoma NCCIT cells. As shown in Figure 3, UTF1 was
expressed in most of the tested cell lines although at differ-
ent levels. Indeed, Ishikawa (endometrium), HCT116
(colon) and Detroit 562 (pharynx) cell lines showed high
levels of UTF1 expression compared to NCCIT differenti-
ated with retinoic acid. On the contrary, weak UTF1 expres-
sion was detected in DU146 (prostate) and EO33
(oesophagus). We also investigated the expression of Sox2
and Oct4A, which were reported to regulate UTF1 expres-
sion in stem cells (Nishimoto et al. 1999). As expected, with
the exception of undifferentiated NCCIT, Oct4A was not
detected in any of the analysed cell lines. However, in addi-
tion to NCCIT, Sox2 was also seen in Detroit 562, but not
in the other cell lines.
Expression profile of UTF1 in human somatic epithelial
cancers
We previously found that UTF1 overexpression is associated
with cervical carcinogenesis (Guenin et al. 2012), and we
therefore investigated whether UTF1 exhibited a specific pat-
tern in the human epithelial tumours in comparison with
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Figure 1 Immunohistochemical staining of undifferentiated cell transcription factor (UTF)1 in various normal human epithelia. UTF1
expression was detected in all tested tissues as shown here in representative images. (A) Endometrium, (B) Breast, (C) Bladder, (D)
Prostate, (E) Colon, (F) Oesophagus, (G) Lung and (H) Kidney. Positive control (testis) is displayed in (I). Corresponding negative
controls are shown in images indicated by lower case letters (a–i). Magnification 9200. Scale bar 100 lm.
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their healthy counterparts. Thus, UTF1 expression was im-
munohistochemically analysed in epithelial tumour samples
including 29 endometrioid adenocarcinomas, 9 breast carci-
nomas, 12 bladder transitional carcinomas, 10 prostatic
adenocarcinomas, 12 primary colon adenocarcinomas, 14
oesophagus SCC, 8 lung SCC and 10 renal clear cell carci-
nomas. As shown in Figure 4, UTF1 immunoreactivity was
seen in all tumour cases with the exception of one bladder
and three colon samples. Representative images are dis-
played in Figure 4.
The semi-quantitative analysis of the staining in the
tumour samples (Figure 5) revealed a significant increase in
UTF1 expression in endometrial and prostatic adenocarcino-
mas (P < 0.01 and P < 0.05, respectively), whereas a signifi-
cant decrease in UTF1 staining intensity was observed in
colorectal adenocarcinomas (P < 0.001) and renal clear cell
carcinomas (P < 0.001) in comparison with control tissues.
The expression of UTF1 was similar in breast, bladder, lung
and oesophageal tumours and controls.
Discussion
The specificity of some SC markers is currently under con-
siderable debate. Indeed, numerous studies have reported
the expression of some of them within normal somatic
tissues, especially in epithelia. For example, Sox2 was found
to be widely expressed in normal oesophageal (Gen et al.
2010), gastric (Otsubo et al. 2011) and lung epithelia (Wil-
bertz et al. 2011). A recent study also reported Oct4A
expression by the epithelial cells within the human urogeni-
tal tract (Kristensen et al. 2010). Similarly, it was discovered
that CD133 was not restricted to stem cells, as it was ubiq-
uitously detected in differentiated epithelia in both murine
and human colon mucosa (Shmelkov et al. 2008).
For many years, UTF1 was considered to be expressed
exclusively in SC and gonadal cells in adults. Recently,
Table 1 Statistical analysis of undifferentiated cell transcription factor 1 staining in normal human epithelial tissue. Comparison
between tissues was performed using one-way ANOVA followed by Tukey’s multiple comparison test
P Prostate Endometrium Bladder Colon Oesophagus Lung Kidney
Breast ns ns ns <0.05 <0.01 <0.001 <0.0001
Prostate ns ns ns <0.01 <0.001 <0.0001
Endometrium ns ns <0.01 <0.001 <0.0001
Bladder ns ns ns <0.001
Colon ns ns <0.05
Oesophagus ns ns
Lung ns
Figure 2 Undifferentiated cell transcription factor (UTF)1
expression profile in normal epithelia. UTF1 expression level
was evaluated according to the semi-quantitative analysis
described in the Materials and Methods section. Statistical
analysis of staining is displayed in Table 1.
Figure 3 Western blot analysis of undifferentiated cell
transcription factor 1, Sox2 and Oct4A expression in somatic
epithelial cell lines. Actin was used as the loading control.
White bars: line showing the removal of a lane from the
original image of the gels that was not used for the purpose of
this work.
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Kristensen and collaborators demonstrated the presence of
UTF1 in normal epithelia from the human genital tract
including the prostate, epididymis and seminal vesicle (Kris-
tensen et al. 2010). Nevertheless, the authors did not discuss
the fact that UTF1 protein could not be restricted to stem
cells. More recently, Reinisch and collaborators demon-
strated widespread UTF1 expression in normal skin epithe-
lium, which was not restricted to skin SC. In that study, the
authors questioned whether UTF1 is a skin SC marker and
highlighted its role, not in SC fate determination, but rather
in keratinocyte differentiation (Reinisch et al. 2011).
Recently, we showed that UTF1 was expressed in the nor-
mal cervical epithelium as well as in some cervical cell lines
(Guenin et al. 2012). However, its expression and distribu-
tion patterns in other human tissues were not characterized.
In the present study, we showed that UTF1 is widely
expressed in normal human epithelial tissues, but, very rarely,
in the stroma underlying the epithelial cells. Remarkably,
UTF1 was differentially expressed according to the tissue
type, at a markedly high level in the kidneys and at the lowest
levels in breast, endometrium and prostate. In agreement with
previously published data on ESC (van den Boom et al.
Figure 4 Undifferentiated cell transcription factor (UTF)1 expression in human epithelial tumours. Representative UTF1
immunostaining in tumour samples is shown in the main pictures, magnification 9200.
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2007), the immunostaining was almost always seen within
the nucleus. In addition and consistent with the results found
in skin epithelium (Reinisch et al. 2011), we noticed that
UTF1 was more highly expressed in cells within the supraba-
sal layers. Such a pattern was clearly seen in the bladder,
prostate and breast epithelia (Figure 1C and Supplementary
Figure 1). These results suggest that UTF1 could be required
at least for the initiation and progress of epithelial cell differ-
entiation process. This hypothesis is supported by the fact
that UTF1 depletion in ESC and ECC resulted in delayed or
blocked differentiation (van den Boom et al. 2007).
Molecular analysis of UTF1 in epithelial cell lines demon-
strated its expression at different levels. No differences in
expression were found between EO33 or DU146 cells when
compared to NCCIT differentiated cells. On the contrary,
high UTF1 levels were seen in Ishikawa, HCT116 and
Detroit 562 cells, which is consistent with results revealing
the expression of UTF1 mRNA and protein in human
somatic cell lines such as skin and cervical keratinocytes
(Reinisch et al. 2011; Guenin et al. 2012). Interestingly, we
found that UTF1 expression was not associated with that of
Sox2 and Oct4A in any of the epithelial cell lines. Although
the Detroit 562 cell line expressed Sox2, UTF1 expression
did not seem to be related to that of Sox2. These observa-
tions strongly support the notion that UTF1 is likely to be
regulated by factors other than Oct4A and Sox2. Indeed,
UTF1 was detected in human spermatogonia in foetuses,
children and postpuberty, but its expression was not associ-
ated with that of Sox2 and Oct4A (Wang et al. 2010). In
addition, we previously suggested that methylation of the
UTF1 promoter might play an important role in its expres-
sion (Guenin et al. 2012). However, the mechanisms under-
lying its regulation remain unknown. Thus, further
molecular analyses are necessary to address this issue.
Many of the SC or pluripotency markers have been found
to be involved in tumour development and/or progression.
For example, it was shown that Sox2 was overexpressed in
cervical, skin and penis tumours (Maier et al. 2011). Klf4,
another stem cell marker, was reported to be upregulated in
breast cancers (Foster et al. 2000). Furthermore, it has
recently been shown that CD133 and CD44 were univer-
sally expressed in gastrointestinal stromal tumours (Chen
et al. 2012).
In a pathological context, the analyses performed on ESC
showed that UTF1 expression stimulated cell proliferation
and increased teratoma-forming capability in nude mice (Ni-
shimoto et al. 2005; Jia et al. 2012). Recent work investi-
gated the expression level of UTF1 in some human cancers.
Interestingly, it has been reported that UTF1 could be used
as a diagnostic marker for seminoma and embryonal carci-
noma of the testis (Wang et al. 2010). In somatic tumours,
it was shown that UTF1 mRNA levels could serve to dis-
criminate between stage I–III and IV neuroblastoma (Melone
et al. 2009), and we have recently shown that UTF1 is up-
regulated during cervical carcinogenesis (Guenin et al.
2012).
Consistent with our results in cervical cancer, we found
that UTF1 was significantly upregulated in endometrial and
prostatic cancers, suggesting a potential role for this epige-
netic regulator during genital tract carcinogenesis. It should
be noted that UTF1 was also found to be significantly over-
expressed in endometriosis (Forte et al. 2009). This pathol-
ogy shares many cellular and molecular similarities with
neoplastic development (Forte et al. 2009; Kokcu 2011).
However, in a tumoral context, this is the first time that
UTF1 has been linked to endometrial cancer. This also
raised the possibility of putative hormonal regulation of
UTF1 expression. This should be considered in further stud-
ies. In contrast, significant downregulation of UTF1 was
found in colon and kidney tumours, suggesting a possible
role in colon and renal carcinogenesis.
Altogether, these results suggest that UTF1 could play a
dual role during carcinogenesis. Bivalent function was previ-
ously reported for some proteins that could act either as
oncogenes or as tumour suppressors in a tissue-dependent
manner. For example, although Sox2 was reported to be up-
regulated in several tumours, it was found to be downregu-
lated in gastric cancer (Otsubo et al. 2008). This dual
behaviour was seen for other markers such as Klf4, which is
overexpressed in 70% of breast cancers, but inhibited in
colorectal neoplasia (Foster et al. 2000; Patel et al. 2010).
Such distinct expression patterns may be due to a histotype-
specific function of the marker. Therefore, further cellular
and molecular studies investigating, on the one hand, the
role of UTF1 overexpression in genital carcinogenesis and,
on the other hand, the role of its downregulation in renal
and colon cancers could be of considerable interest.
In conclusion, we have shown, for the first time, that
UTF1 is widely expressed in human epithelia with a nuclear
localization. This distribution does not fit with the idea of
its exclusive expression in stem cells and pinpoints a role of
UTF1 in epithelial cell physiology. Moreover, we have
shown that UTF1 is significantly upregulated in endometrial
Figure 5 Variation in undifferentiated cell transcription factor
(UTF)1 expression between tumours and normal epithelia.
Semi-quantitative analyses of UTF1 expression in tumour
samples were performed as described in the Materials and
Methods section. The expression level of UTF1 in cancer was
compared to that of normal tissues. Asterisks indicate
statistically significant differences (*P < 0.05; **P < 0.01;
***P < 0.001; Student t-test).
International Journal of Experimental Pathology, 2014, 95, 251–259
UTF1 expression in normal and cancerous human epithelia 257
and prostate cancers, but downregulated in kidney and
colon cancers. These patterns indicate that UTF1 might play
an important role in carcinogenesis but with relative tissue
specificity. These findings open new perspectives in investi-
gating the role of UTF1 in cell physiology and cancer.
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